Search

everythinglearnresearchcommunity

for

Search:↓

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Toxic metals can cause hair loss and should be considered by doctors.

Certain foods and supplements can help treat skin diseases alongside medication.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

New techniques can effectively treat aging around the eyes.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Histone modification is key in treating chronic inflammatory skin diseases.